phosphatidylcholines has been researched along with eptifibatide in 1 studies
| Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (eptifibatide) | Trials (eptifibatide) | Recent Studies (post-2010) (eptifibatide) |
|---|---|---|---|---|---|
| 32,204 | 443 | 5,593 | 907 | 220 | 212 |
| Protein | Taxonomy | phosphatidylcholines (IC50) | eptifibatide (IC50) |
|---|---|---|---|
| Integrin beta-3 | Homo sapiens (human) | 0.226 | |
| Integrin alpha-IIb | Homo sapiens (human) | 0.226 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alt, K; Bonnard, T; Hagemeyer, CE; Hoefer, T; Kammoun, H; Molloy, CP; Murphy, AJ; Peter, K; Ramsland, PA; Rosengarten, G; Tovar-Lopez, F; van den Berg, A; van der Meer, AD; Westein, E; Yao, Y | 1 |
1 other study(ies) available for phosphatidylcholines and eptifibatide
| Article | Year |
|---|---|
Shear-sensitive nanocapsule drug release for site-specific inhibition of occlusive thrombus formation.
Topics: Animals; Arterial Occlusive Diseases; Biomechanical Phenomena; Blood Flow Velocity; Delayed-Action Preparations; Disease Models, Animal; Drug Compounding; Drug Delivery Systems; Eptifibatide; Fibrinolytic Agents; Hemorrhage; Mice, Inbred C57BL; Nanocapsules; Peptides; Phosphatidylcholines; Platelet Aggregation; Platelet Aggregation Inhibitors; Regional Blood Flow; Stress, Mechanical; Thrombosis | 2017 |